Back to search

Article

DAMP-inducing Peptide Nanofibers and PAMP Combination Adjuvants Boost Functional Lung Tissue-resident Memory CD4 <sup>+</sup> T Cell Responses

2024-08-29

Abstract excerpt

<h4>ABSTRACT</h4> Vaccine adjuvants are typically composed of pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) that activate innate immune cells. Advances in basic immunology have demonstrated the need for various ‘types’ of protective immunity, which are difficult to achieve with a single adjuvant. The FDA approval of multiple PAMP-DAMP combinations for clinical use...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a76fb458-5859-5a29-8bcb-286818ecec16
DOI
10.1101/2024.08.28.610131
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DAMP-inducing Peptide Nanofibers and PAMP Combination Adjuvants Boost Functional Lung Tissue-resident Memory CD4 <sup>+</sup> T Cell ResponsesDOI 10.1101/2024.08.28.610131
A vaccine targeting lung resident-memory CD4+ T cell phenotype protects against Mycobacterium tuberculosis in miceSemantic proximity
Hybrid Bacterial Membrane Nanovaccine Reprograms the Tuberculosis Immune Microenvironment via CD40 to Surpass BCG ProtectionSemantic proximity
MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primatesSemantic proximity
Amphiphile-engineered DNA adjuvants stimulate strong type I IFN production in lymph nodes via cytosolic danger-sensing to induce potent cellular and humoral immunity in mice and non-human primatesSemantic proximity
Improved Immune Responses and Tuberculosis Protection by Aerosol Vaccination with recombinant BCG expressing ESX-1 from <i>Mycobacterium marinum</i>Semantic proximity
Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization.Semantic proximity
Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge.Semantic proximity
Mucosal BCG vaccination reprograms lung interstitial macrophages and enhances antimicrobial defense in miceSemantic proximity
Protective intravenous BCG vaccination induces enhanced immune signaling in the airwaysSemantic proximity
CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.Semantic proximity
Therapeutic DNA Vaccine Targeting <i>Mycobacterium tuberculosis</i> Persisters Shortens Curative Tuberculosis TreatmentSemantic proximity
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-GuérinSemantic proximity
Select a neighboring publication to make it the new centre.